Establish and analyse a model of care for the management of people taking oral anti-cancer medications by an Advanced Nurse Practitioner: a pilot study

Establish and analyse the safety and efficacy of an integrated care model for the management of patients receiving oral anti-cancer agents in the community by an Advanced Nurse Practitioner (ANP): a pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN10401455

Enrollment

Registered

2020-11-30

Start date

2020-09-13

Completion date

Unknown

Last updated

2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Individuals with cancer or taking oral anti-cancer medication (OAMs) Cancer

Interventions

This is a two-phase study, aiming to: 1. Design an ANP integrated oncology care model for the administration of OAM with input from local and national stakeholders and existing literature 2. Pilot tes

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Currently receiving an oral anti-cancer treatment 2. Have received OAM within 6 months of data collection commencing 3. Aged 18 years and over 4. Cognitively able to provide informed consent and complete the study activities 5. An ECOG performance status of 0-2

Exclusion criteria

Exclusion criteria: 1. Refusal to participate 2. Patients not taking oral anticancer medication.

Design outcomes

Primary

Measure	Time frame
1. Quality of life measured using the EQ-5D-5L questionnaire at baseline and 6-month follow-up 2. The experiences of patients and healthcare providers gathered using qualitative interviews/focus groups at one timepoint during the intervention	—

Secondary

Measure	Time frame
1. Quantitative data describing the intervention, e.g. patient waiting time, and intervention outcomes, e.g. adverse events and toxicity, gathered using study logs and predesigned forms. Toxicity grading system will be used throughout. The forms to capture the specific data will be unique to this study and developed for its purpose. This data will be captured at each patient visit and will continue to be captured throughout the study period. 2. Healthcare resource use measured using questionnaire at baseline and 6-month follow-up	—

Measure

Time frame

1. Quantitative data describing the intervention, e.g. patient waiting time, and intervention outcomes, e.g. adverse events and toxicity, gathered using study logs and predesigned forms. Toxicity grading system will be used throughout. The forms to capture the specific data will be unique to this study and developed for its purpose. This data will be captured at each patient visit and will continue to be captured throughout the study period. 2. Healthcare resource use measured using questionnaire at baseline and 6-month follow-up

—

Countries

Ireland

Contacts

Public ContactJanice Richmond

janicep.richmond@hse.ie+353 (0)749123648

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 11, 2026